Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Kollmeier
    Kollmeier
  2. Zhang
    Zhang
  3. Yamada
    Yamada
  4. McBride
    McBride
  5. Romesser
    Romesser
  6. Beattie
    Beattie
  7. Deasy
    Deasy
  8. Golia Pernicka
    Golia Pernicka
  9. Jackson
    Jackson
  10. Jain
    Jain

Groups

  1. Radiation Oncology, Department of (10)
  2. Survivorship Research (10)
  3. Biostatistics Service (5)
  4. Epidemiology and Biostatistics (5)
  5. GDMT, Radiation Oncology (5)
  6. Gynecology Disease Management Team (5)
  7. Sloan Kettering Institute Postdocs (4)
  8. Medical Physics (3)
  9. Molecular Imaging and Therapy Service (2)
  10. Radiology, Department of (2)
Search Within
  1. "Journal article"
  2. "Daniel Spratt"
Formats
  1. Journal Article (11)
Groups
  1. Radiation Oncology, Department of (10)
  2. Survivorship Research (10)
  3. Biostatistics Service (5)
  4. Epidemiology and Biostatistics (5)
  5. GDMT, Radiation Oncology (5)
  6. Gynecology Disease Management Team (5)

More Groups

People
  1. Daniel Spratt (11)
  2. Michael Zelefsky (10)
  3. Marisa Kollmeier (5)
  4. Zhigang Zhang (5)
  5. Xin Pei (4)
  6. Yoshiya Yamada (4)

More People

Years
  1. 2017 (1)
  2. 2015 (2)
  3. 2014 (1)
  4. 2013 (7)
Publications
  1. European Urology (6)
  2. Brachytherapy (3)
  3. Journal of Urology (2)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patterns of lymph node failure after dose-escalated radiotherapy: Implications for extended pelvic lymph node coverage
    Journal Article

    Spratt, D. E.; Vargas, H. A.; Zumsteg, Z. S.; Golia Pernicka, J. S.; Osborne, J. R.; Pei, X.; Zelefsky, M. J.
    European Urology (2017)

    Fulltext@MSK | Save
  • Anatomical patterns of recurrence following biochemical relapse in the dose escalation era of external beam radiotherapy for prostate cancer
    Journal Article

    Zumsteg, Z. S.; Spratt, D. E.; Romesser, P. B.; Pei, X.; Zhang, Z.; Kollmeier, M.; McBride, S.; Yamada, Y.; Zelefsky, M. J.
    Journal of Urology (2015)

    Fulltext@MSK | Save
  • The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy
    Journal Article

    Zumsteg, Z. S.; Spratt, D. E.; Romesser, P. B.; Pei, X.; Zhang, Z. G.; Polkinghorn, W.; McBride, S.; Kollmeier, M.; Yamada, Y.; Zelefsky, M. J.
    European Urology (2015)

    Fulltext@MSK | Save
  • A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomy
    Journal Article

    Osborne, J. R.; Green, D. A.; Spratt, D. E.; Lyashchenko, S.; Fareedy, S. B.; Robinson, B. D.; Beattie, B. J.; Jain, M.; Lewis, J. S.; Christos, P.; more...
    Journal of Urology (2014)

    Fulltext@MSK | Save
  • A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy
    Journal Article

    Zumsteg, Z. S.; Spratt, D. E.; Pei, I.; Zhang, Z.; Yamada, Y.; Kollmeier, M.; Zelefsky, M. J.
    European Urology (2013)

    Fulltext@MSK | Save
  • Patterns and predictors of amelioration of genitourinary toxicity after high-dose intensity-modulated radiation therapy for localized prostate cancer: Implications for defining postradiotherapy urinary toxicity
    Journal Article

    Ghadjar, P.; Jackson, A.; Spratt, D. E.; Oh, J. H.; Munck Af Rosenschold, P.; Kollmeier, M.; Yorke, E.; Hunt, M.; Deasy, J. O.; Zelefsky, M. J.
    European Urology (2013)

    Fulltext@MSK | Save
  • Rebuttal to Dr. Stone
    Journal Article

    Spratt, D. E.; Zelefsky, M. J.
    Brachytherapy (2013)

    Fulltext@MSK | Save
  • Point: There is a need for supplemental XRT with brachytherapy in the treatment of intermediate-risk prostate cancer patients
    Journal Article

    Spratt, D. E.; Zelefsky, M. J.
    Brachytherapy (2013)

    Fulltext@MSK | Save
  • A comparative dosimetric analysis of virtual stereotactic body radiotherapy to high-dose-rate monotherapy for intermediate-risk prostate cancer
    Journal Article

    Spratt, D. E.; Scala, L. M.; Folkert, M.; Voros, L.; Cohen, G. N.; Happersett, L.; Katsoulakis, E.; Zelefsky, M. J.; Kollmeier, M. A.; Yamada, Y.
    Brachytherapy (2013)

    Fulltext@MSK | Save
  • Reply to Leah Bensimon, Samy Suissa, and Laurent Azoulay's letter to the editor re: Daniel E. Spratt, Chi Zhang, Zachary S. Zumsteg, Xin Pei, Zhigang Zhang, Michael J. Zelefsky. Metformin and prostate cancer: Reduced development of castration-resistant disease and prostate cancer mortality. Eur Urol 2013;63:709-16
    Journal Article

    Spratt, D. E.; Zhang, Z.; Zelefsky, M. J.
    European Urology (2013)

    Fulltext@MSK | Save